180 related articles for article (PubMed ID: 15351315)
1. An in vitro investigation of the effects of the nerve agent pretreatment pyridostigmine bromide on human peripheral blood T-cell function.
Telford G; Wilkinson LJ; Hooi DS; Worrall V; Green AC; Cook DL; Pritchard DI; Griffiths GD
Int Immunopharmacol; 2004 Nov; 4(12):1455-66. PubMed ID: 15351315
[TBL] [Abstract][Full Text] [Related]
2. A T-cell-dependent humoral immune response is preserved during the administration of the nerve agent pre-treatment pyridostigmine bromide in a murine model.
Griffiths GD; Telford G; Hooi DS; Cook DL; Wilkinson LJ; Green CA; Pritchard DI
Int Immunopharmacol; 2005 Mar; 5(3):525-40. PubMed ID: 15683849
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
4. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
[TBL] [Abstract][Full Text] [Related]
5. Naive human T-cells become non-responsive towards anti-TNFalpha (infliximab) treatment in vitro if co-stimulated through CD28.
Gunnlaugsdottir B; Skaftadottir I; Ludviksson BR
Scand J Immunol; 2008 Dec; 68(6):624-34. PubMed ID: 19000096
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
7. Platelets inhibit in vitro response of lymphocytes to mitogens.
Wang Y; Niu J
Immunol Lett; 2008 Aug; 119(1-2):57-61. PubMed ID: 18514331
[TBL] [Abstract][Full Text] [Related]
8. Soluble mediators from human neural stem cells play a critical role in suppression of T-cell activation and proliferation.
Kim SY; Cho HS; Yang SH; Shin JY; Kim JS; Lee ST; Chu K; Roh JK; Kim SU; Park CG
J Neurosci Res; 2009 Aug; 87(10):2264-72. PubMed ID: 19301423
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholine-esterase inhibitor pyridostigmine decreases T cell overactivation in patients infected by HIV.
Valdés-Ferrer SI; Crispín JC; Belaunzarán PF; Cantú-Brito CG; Sierra-Madero J; Alcocer-Varela J
AIDS Res Hum Retroviruses; 2009 Aug; 25(8):749-55. PubMed ID: 19645607
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
[TBL] [Abstract][Full Text] [Related]
11. Studies on immunomodulatory properties of isoniazid. I. Effect of isoniazid on mitogen- and anti-CD3 antibody-induced proliferation of human peripheral blood mononuclear cells and T cells.
Kucharz EJ; Sierakowski SJ
J Hyg Epidemiol Microbiol Immunol; 1990; 34(1):99-105. PubMed ID: 2141035
[TBL] [Abstract][Full Text] [Related]
12. MUC1 mucin-mediated regulation of human T cells.
Agrawal B; Longenecker BM
Int Immunol; 2005 Apr; 17(4):391-9. PubMed ID: 15710907
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
Tenorio EP; Saavedra R
Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
[TBL] [Abstract][Full Text] [Related]
15. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.
Watanabe N; Narita M; Yokoyama A; Sekiguchi A; Saito A; Tochiki N; Furukawa T; Toba K; Aizawa Y; Takahashi M
Cytotherapy; 2006; 8(2):118-29. PubMed ID: 16698685
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation.
MacMillan HF; Lee T; Issekutz AC
Clin Immunol; 2009 Aug; 132(2):222-33. PubMed ID: 19447680
[TBL] [Abstract][Full Text] [Related]
17. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
Watson CL; Furlong SJ; Hoskin DW
Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
[TBL] [Abstract][Full Text] [Related]
18. Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes.
Chavez-Rueda K; Hérnández J; Zenteno E; Leaños-Miranda A; Legorreta-Haquet MV; Blanco-Favela F
Clin Immunol; 2005 Aug; 116(2):182-91. PubMed ID: 15993365
[TBL] [Abstract][Full Text] [Related]
19. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
Herkert NM; Eckert S; Eyer P; Bumm R; Weber G; Thiermann H; Worek F
Toxicology; 2008 Apr; 246(2-3):188-92. PubMed ID: 18304715
[TBL] [Abstract][Full Text] [Related]
20. The immune privilege of the eye: human retinal pigment epithelial cells selectively modulate T-cell activation in vitro.
Kaestel CG; Lovato P; Ødum N; Nissen MH; Röpke C
Curr Eye Res; 2005 May; 30(5):375-83. PubMed ID: 16020268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
